Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto


   0 (0%) 09-28 20:57
Open: Pre. Close:
High: Low:
Volume: 0 Market Cap: 0(M)

Technical analysis

as of: 2023-09-28 4:51:40 PM
Short-term rate:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Mid-term rate:       
Target: Six months: 21.04     One year: 24.58
Support: Support1: 16.89    Support2: 16.2
Resistance: Resistance1: 18.02    Resistance2: 21.04
Pivot: 17.12
Moving Average: MA(5): 16.93     MA(20): 17.15
MA(100): 15.97     MA(250): 14.48
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 57.5     %D(3): 36.4
RSI: RSI(14): 53
52-week: High: 20.64  Low: 10.28
Average Vol(K): 3-Month: 488 (K)  10-Days: 293 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ KNSA ] has closed below upper band by 28.6%. Bollinger Bands are 56.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.96 - 18.07 18.07 - 18.16
Low: 16.94 - 17.05 17.05 - 17.15
Close: 17.26 - 17.44 17.44 - 17.6

Company Description

Headline News

Thu, 28 Sep 2023
Amicus Therapeutics Upgrades RS Rating to 82, Becomes a Stock ... - Clayton County Register

Thu, 28 Sep 2023
Amicus Therapeutics Stock Reaches 80+ Relative Strength ... - Investor's Business Daily

Fri, 15 Sep 2023
Legato Capital Management LLC Buys New Position in Kiniksa ... - MarketBeat

Wed, 13 Sep 2023
Stocks With Rising Relative Strength: Ionis Pharmaceuticals - Investor's Business Daily

Fri, 08 Sep 2023
Ventyx Biosciences Gets Relative Strength Rating Upgrade - Investor's Business Daily

Fri, 08 Sep 2023
Intra-Cellular Therapies Shows Improved Relative Strength; Still Shy ... - Investor's Business Daily

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. 35 (M)
Shares Float 30 (M)
% Held by Insiders 4.6 (%)
% Held by Institutions 96.3 (%)
Shares Short 3,850 (K)
Shares Short P.Month 3,440 (K)

Stock Financials

EPS 3.21
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.88
Profit Margin (%) 82.3
Operating Margin (%) 13.5
Return on Assets (ttm) 6.8
Return on Equity (ttm) 81.8
Qtrly Rev. Growth 165
Gross Profit (p.s.) 4.91
Sales Per Share 7.96
EBITDA (p.s.) 1.14
Qtrly Earnings Growth 0
Operating Cash Flow 42 (M)
Levered Free Cash Flow 37 (M)

Stock Valuations

PE Ratio 5.42
PEG Ratio 0.5
Price to Book value 2.96
Price to Sales 2.18
Price to Cash Flow 14.45

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.